Finding companies with the criteria you want isn’t always easy. You could spend hours searching ticker after ticker, only to find companies which aren’t worthy of your hard earned cash. An easier way to navigate through this is by using high quality stock screeners. Screening helps investors narrow down companies to invest in based on their ability to meet every criteria selected.  Any company who misses even one of the criteria requirements will be filtered out.

This lets one easily choose ideal metrics. Screens are effective because they sift out bad stocks and only keep the cream of the crop in.  It isn’t always easy to create an effective screen. Our Zacks Premium Screens have helped with this, bringing profits to many investors over time.  Our predefined criteria are chosen carefully to capture special kinds of companies.

Today, we’ve dug up three tech stocks using one of our premium screens known as “Zacks #1 Growth Stocks”. Some of the metrics of this screen is that the stock must have an average trading volume of at least 100,000 shares over the last 20 days, a Zacks Rank #1 (Strong Buy), and expected earnings growth north of 20% this year. In addition to using the metrics on this great screen, I’ve added an additional metric which I feel is appropriate for investing in growth stocks 

I screened for stocks with a PEG under one. The PEG we use applies a 3-5 year projected growth rate. This was done so that I could find companies that are trading at a discount relative to their expected growth rate. Let’s see what our modified premium screen has found for us today.

Emergent Biosolutions Inc-(EBS – Analyst Report)

Emergent is a leading biopharmaceutical company that manufactures vaccines and therapeutics in order to help boost the immune system. The company’s solutions are also developed so that they can treat and prevent diseases. EBS is a Zacks Rank #1 (Strong Buy), and also sees a healthy average daily trading volume of 432,794 shares. The company expects to grow its earnings by 22.5% this year.